Latest Kaiser Health News Stories
House Republicans want to repeal federal tax credits that have helped spur a boom in orphan drugs for rare diseases.
A flurry of federal and state probes have targeted insulin manufacturers and pharmacy benefit managers — middlemen in the prescription drug-pricing pipeline. Here, we connect the legal dots.
Over the past two years, a powerful federal prosecutor and several state attorneys general have launched investigations related to diabetes drugs.
Nursing generally offers stable earnings and low unemployment, which likely sounds good to young adults who came of age during the Great Recession.
U.S. hospice agencies promise to be available around-the-clock to help patients dying in their homes. But a Kaiser Health News investigation shows that in an alarming number of cases, that promise is broken.
U.S. District Judge Vince Chhabria said the vast majority of states have already prepared for the termination of the payments and already devised responses that give consumers better coverage.
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
Patients flocked to researcher who ignored usual patient protections, as university claimed ignorance.
They say it will help reduce unnecessary ER visits and ensure better follow-up care. It’s also good P.R., and helps them meet their obligations to provide benefits to the community in exchange for significant tax breaks.
The strategy has been used mostly in Indiana, where many county-owned hospitals purchased or leased nursing homes to take advantage of a wrinkle in Medicaid payment rules and augment federal reimbursements.
Long commutes and scarcity of providers make it hard for patients who need counseling or psychiatric care.
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
After regulators questioned Anthem’s forecast for medical costs, the company agreed to reduce rate hikes on its individual and small-business health plans next year, saving customers an estimated $114 million.
A new link creates two-way access to the state registry that documents the type of medical care sick and frail patients want — or refuse.
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
Eight teaching centers in California aim to train and retain doctors in medically underserved areas such as California’s Central Valley. They are among 57 such institutions across the country that may soon receive a boost in funding from Congress.
“If it gets signed by this governor, it’s going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
Hospitals view adding trauma care as a potential profit tool, but experts say having more centers does not necessarily improve the system’s ability to respond to a mass casualty event.
The inspector general at Health and Human Services says defective pacemakers or defibrillators had to be replaced from 2005 through 2014, costing Medicare $1.5 billion.
Tom Price resigned from running the Department of Health and Human Services after a series of news stories detailing how he tallied more than $400,000 in private plane travel paid for by taxpayers.